Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Pediatrix Medical Group, Inc. is a physician-led healthcare services company focused on providing specialized medical care for women, infants, and children. The company operates primarily within the healthcare services industry, delivering care in hospital-based and outpatient settings through long-term service agreements with healthcare facilities. Its core activities center on neonatal, maternal-fetal, and pediatric subspecialty care, making it a key provider within perinatal and pediatric medicine in the United States.
The company generates the majority of its revenue from professional medical services reimbursed by commercial insurers, government healthcare programs, and managed care organizations. Pediatrix Medical Group evolved from its former corporate identity, MEDNAX, Inc., and formally adopted the Pediatrix Medical Group name to reflect its strategic refocus on its historical strengths in neonatology and pediatric subspecialties after divesting non-core service lines. Its strategic positioning emphasizes clinical depth, scale, and long-standing hospital partnerships.
Business Operations
Pediatrix Medical Group’s operations are organized around its physician practice management model, supporting affiliated clinicians with administrative, billing, compliance, and clinical infrastructure. Its primary business segments include Neonatology, Maternal-Fetal Medicine, Pediatric Cardiology, Pediatric Intensive Care, Pediatric Hospital Medicine, and Obstetric Services, which collectively represent the company’s principal revenue drivers.
The company operates almost entirely within the United States and provides care across hundreds of hospitals and outpatient clinics. Pediatrix controls centralized clinical support systems, revenue cycle management platforms, and quality reporting infrastructure through its operating subsidiary Pediatrix Medical Services, Inc. The company maintains contractual relationships with hospitals rather than owning facilities, enabling an asset-light operating model.
Strategic Position & Investments
Pediatrix Medical Group’s strategic direction is centered on deepening its leadership in neonatal and pediatric subspecialty care while improving operational efficiency and clinical outcomes. The company has emphasized organic growth through expanding service offerings within existing hospital partnerships and recruiting subspecialist physicians in high-demand pediatric fields.
In recent years, Pediatrix completed divestitures of its former anesthesiology and radiology businesses to sharpen its focus on women’s and children’s healthcare. The company continues to invest in clinical data analytics, telemedicine capabilities, and quality improvement initiatives designed to support value-based care arrangements. Data inconclusive based on available public sources regarding material acquisitions following the completion of these divestitures.
Geographic Footprint
Pediatrix Medical Group is headquartered in Florida and maintains a broad operational presence across the United States, serving hospitals and clinics in numerous states. Its physicians practice in urban, suburban, and regional healthcare systems, providing the company with nationwide coverage in neonatal and pediatric subspecialty services.
The company does not report material international operations, and its revenue is overwhelmingly derived from U.S.-based healthcare services. Its geographic influence is primarily defined by regional hospital networks and long-standing service contracts rather than owned international assets.
Leadership & Governance
Pediatrix Medical Group is led by an executive team with extensive experience in physician practice management, healthcare operations, and clinical leadership. The company emphasizes a physician-led governance model focused on clinical quality, operational discipline, and alignment with hospital partners.
Key members of the leadership team include:
- Mark S. Ordan – Chief Executive Officer
- Brian C. Decker – Chief Financial Officer
- Jeffrey R. Steinhubl, MD – Chief Medical Officer
- Jill C. Brown – Chief Administrative Officer
- Craig S. McKeever – Chief Compliance Officer
The leadership team’s strategic vision centers on reinforcing Pediatrix’s position as a leading provider of specialized care for women and children while adapting to evolving reimbursement models and healthcare delivery trends.